Physicians' Academy for Cardiovascular Education

Managing the acute coronary syndrome: What is new?

Slides (presentation) - June 24, 2011

Managing the acute coronary syndrome: What is new?

Prof. Adam Timmis
Barts and the London School of Medicine and Dentistry
University of London


To view presentation, click on slides below


Potential drivers of reduced AMI rates
What about revascularisation?
Summary 1.
Life Saving Strategies in AMI
33% of people who die from AMI do so before they reach hospital
BHF Doubt Kills Campaign
Summary 2.
Life Saving Strategies in AMI
STEMI: reperfusion therapy
Impact of door to balloon time
Culprit only vs complete revascularisation in STEMI:
DES vs BMS for primary PCI:
Dual antiplatelet therapy (DAPT) - continue for 12 months after DES
New Inhibitors of the platelet the ADP P2Y12 receptor
PLATO: ticagrelor vs clopidogrel in ACS
NSTEMI: emergency treatment
NSTEMI: don’t under-estimate it
Trials of Invasive vs Conservative Treatment Strategy in NSTEMI
Routine Versus Selective Invasive Strategy in NSTEMI
Life Saving Strategies in AMI
Adjusted KM curves: 1 yr survival by number of 2° prevention drugs
Impact of under-utilisation:
GPRD: Continuing statin therapy in 12m post ACS
Discontinuation of clopidogrel(“non-compliance”) after discharge
Summary 4.
Life Saving Strategies in AMI
Implantable defibrillator post AMI
The revolution for coronary outcomes in east London

Download teaching slides

Share this page with your colleagues and friends: